Preimplantation Genetic Diagnostics Market

Preimplantation genetic diagnosis?(PGD) is a procedure used prior to implantation to help identify?genetic?defects within embryos. This serves to prevent certain?geneticdiseases or disorders from being passed on to the child.

Preimplantation Genetic Diagnostics Market contains market size and forecasts of Preimplantation Genetic Diagnostics (PGD) in Global, including the following market information:

Global Preimplantation Genetic Diagnostics (PGD) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Preimplantation Genetic Diagnostics (PGD) market was valued at 104.6 million in 2021 and is projected to reach US$ 138.6 million by 2028, at a CAGR of 4.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Preimplantation Genetic Screening Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Preimplantation Genetic Diagnostics (PGD) include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Cooper Surgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Preimplantation Genetic Diagnostics (PGD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Preimplantation Genetic Diagnostics (PGD) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, by Type, 2021 (%)

Preimplantation Genetic Screening

Preimplantation Genetic Diagnosis

Global Preimplantation Genetic Diagnostics (PGD) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, by Application, 2021 (%)

Fertility Clinics

Academic Medical Centers

Others

Global Preimplantation Genetic Diagnostics (PGD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Preimplantation Genetic Diagnostics (PGD) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Preimplantation Genetic Diagnostics (PGD) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Illumina, Inc.

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

Perkinelmer, Inc.

Cooper Surgical

ABBott Laboratories

Natera, Inc.

Rubicon Genomics

Oxford Gene Technology

Yikon Genomics

Scigene

Beijing Genomics Institute (BGI)

Genea Limited

Hamilton Thorne

FUJIFILM Irvine Scientific

Nidacon International

Vitrolife AB

Merck

INVO Bioscience

IVFtech

Gonagen Medikal

Cook Medical

CellCura